News Summary

Baxter Canada’s Volara Oscillation and Lung Expansion (OLE) system is making significant strides in improving care for patients with cystic fibrosis (CF) and bronchiectasis. Implemented at the Foothills Medical Centre in Calgary, the system has shown dramatic results in clearing airways of patients who struggle with thick mucus, by using alternating cycles of continuous positive expiratory pressure and high frequency oscillation, along with aerosol delivery. Dr. Christina Thornton of the University of Calgary reports that the system has reduced oxygen dependency in patients and expedited their discharge. Since its introduction in 2024, the Volara system has been adopted for use beyond extreme cases, including post-op thoracic patients and those with lung cancer. Baxter aims to expand its successful application across Canada’s healthcare landscape.